HUMACYTE INC. - COMMO
5,5000
07-октября-24 15:59:59
15 мин. задержка
Акции
+0,0600
+1,10%
Сегодняшний диапазон
5,3700 - 5,7150
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
23 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Humacyte Expands Board of Directors and Leadership Team with New Appointments
20 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
09 сен 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Humacyte Presents at Multiple Conferences in September 2022
08 сен 2022 08:01:00 Источник Nasdaq GlobeNewswire
-
Humacyte Second Quarter 2022 Financial Results and Business Update
12 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
05 авг 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
25 июл 2022 20:26:26 Источник Nasdaq GlobeNewswire
-
19 июл 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
07 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
29 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.
27 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
21 июн 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Humacyte Presents New Immunogenicity Data on Human Acellular Vessels™ (HAVs™)
08 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Humacyte to Present at the H.C. Wainwright Global Investment Conference
16 май 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Humacyte First Quarter 2022 Financial Results and Business Update
13 май 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
09 май 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
06 май 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
05 апр 2022 08:00:03 Источник Nasdaq GlobeNewswire
-
Humacyte Announces Date of Annual Shareholder Meeting
04 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
29 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire